Epidemiology of hypertension in CKD

Bruce Horowitz1, Dana Miskulin1, Philip Zager1

  • 1University of New Mexico, Albuquerque, NM; Tufts University, Boston, MA; and Dialysis Clinic, Inc, Nashville, TN.

Insights

Hypertension (HTN) and chronic kidney disease (CKD) are major health issues. Blood pressure control in CKD patients, especially minorities, remains challenging and suboptimal despite improvements.

Area of Science:

  • Nephrology
  • Cardiology
  • Public Health

Background:

  • Hypertension (HTN) and chronic kidney disease (CKD) are significant, interconnected global health concerns.
  • Approximately 30% of US adults have HTN, and 15% have CKD, with HTN prevalence and control worsening as kidney function declines.
  • CKD etiology, albuminuria, genetics, socioeconomic status, and lifestyle all impact HTN severity and prevalence.

Purpose of the Study:

  • To review the complex relationship between hypertension and chronic kidney disease.
  • To highlight disparities in HTN prevalence, treatment, and outcomes among CKD patients.
  • To discuss challenges in blood pressure control for individuals with CKD.

Main Methods:

  • Literature review and synthesis of current research on HTN and CKD.
  • Analysis of epidemiological data on HTN and CKD prevalence and control.
  • Examination of factors influencing HTN severity and treatment resistance in CKD.

Main Results:

  • HTN is highly prevalent in CKD patients, often more difficult to control, and treatment can be resistant.
  • Racial and ethnic disparities exist in HTN prevalence, BP control, and CKD progression among CKD patients.
  • Blood pressure control in Hispanic and African Americans with CKD is notably worse compared to white individuals.

Conclusions:

  • Despite improvements, blood pressure control in patients with all stages of CKD remains suboptimal.
  • Addressing disparities and improving treatment strategies are crucial for better HTN and CKD management.
  • Further research is needed to elucidate optimal blood pressure targets, particularly in hemodialysis patients.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.2K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
651
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
667
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
792
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.8K